KLOW: KPV, BPC-157, TB-500, GHK-Cu Research Blend Guide
By UK Peptide Lab Research Team•22 May 2026•6 min read
What is KLOW?
KLOW is a pre-blended four-peptide research vial containing KPV (10 mg), BPC-157 (10 mg), TB-500 (10 mg), and GHK-Cu (50 mg), supplied as a single lyophilised powder for one-step reconstitution. KLOW extends the three-peptide GLOW blend by adding KPV, an anti-inflammatory tripeptide derived from the C-terminal of alpha-melanocyte-stimulating hormone. The result is a research blend covering both the regenerative-peptide research axis of GLOW and the mucosal and gut-inflammation research axis associated with KPV.
UK Peptide Lab supplies KLOW with third-party HPLC documentation reporting purity for each component.
KLOW vs GLOW: What KPV Adds
GLOW combines BPC-157, TB-500, and GHK-Cu, the three most commonly co-investigated peptides in tissue-repair and matrix-remodelling research. KLOW adds KPV (lysine-proline-valine), a tripeptide with a different mechanism, namely suppression of nuclear factor kappa B (NF-κB) signalling and reduction of pro-inflammatory cytokine expression in research models.
KPV research has focused on gastrointestinal inflammation models including ulcerative colitis and chemically induced colitis, where the parent peptide α-MSH and its C-terminal fragment have demonstrated anti-inflammatory activity through both melanocortin-dependent and partially melanocortin-independent pathways. See the KPV anti-inflammatory tripeptide research guide for full mechanism detail.
Where GLOW covers connective-tissue and ECM remodelling research, KLOW extends that into mucosal and barrier-immunity research by adding a directly anti-inflammatory tripeptide.
The Four Component Peptides
KPV (3 amino acids, lysine-proline-valine) corresponds to α-MSH(11-13) and is studied for anti-inflammatory effects through NF-κB modulation. See the KPV research guide.
BPC-157 (15 amino acids) is a synthetic pentadecapeptide studied in tissue-repair and angiogenesis research. See the BPC-157 research guide.
TB-500 (17 amino acids in the active fragment) is a synthetic peptide derived from Thymosin Beta-4 and studied in cell-migration and actin-regulation research. See the BPC-157 and TB-500 research overview for context on combined repair-research protocols.
GHK-Cu (3 amino acids plus copper) is a copper-binding tripeptide studied in collagen synthesis and matrix remodelling research. See the GHK-Cu copper peptide research guide.
Research Applications
KLOW is studied in research models that require both regenerative and anti-inflammatory mechanisms in parallel: gut and mucosal repair models, skin and connective-tissue research where inflammatory signalling is also relevant, and broad multi-pathway tissue-repair screening protocols. The four-peptide composition produces overlapping mechanistic coverage rather than a single isolated effect, which is appropriate for combined-pathway research questions and less appropriate for single-mechanism dose-response studies.
Laboratory Handling
KLOW is supplied as a single 80 mg lyophilised vial. Store at -20°C prior to reconstitution. Reconstitute with bacteriostatic water by slowly injecting the diluent down the inner wall of the vial and swirling gently. Never shake. Store the reconstituted solution at 2-8°C and use within 4 weeks. The GHK-Cu component will produce a characteristic blue colour in solution, which is normal. See the peptide reconstitution guide for detailed methodology.
Sourcing in the UK
UK Peptide Lab supplies research-grade KLOW as a pre-blended lyophilised vial with full third-party HPLC documentation reporting purity for each individual component. Same-day UK dispatch on orders placed before 2pm GMT, free Royal Mail Tracked shipping over £45. For in-vitro laboratory research use only, not for human consumption.
Disclaimer: This article is for research and educational purposes only. All information provided is not intended as medical advice. UK Peptide Lab products are not for human consumption and are sold strictly for laboratory research use only.